Research

Funding: Royal Society of Edinburgh (RSE, Stream I - Development Track) , 9.238 EUR

Project Details:
Our research project establishes a strong network between Scotland and Lower Saxony—two regions with a rich agricultural heritage. We explore how positive animal welfare not only improves animal lives but also has lasting effects on sustainability, climate change, food security, human health, and the economy. Positive animal welfare goes beyond preventing suffering—it actively enhances animal well-being and creates benefits for society as a whole. Our discussion will focus on measuring positive animal welfare in farm animals.
Through interdisciplinary collaboration, we foster knowledge exchange, learn from each other, and develop innovative solutions. This network will serve as a foundation for future research projects and strengthen international cooperation. By connecting science, practice, and policy, we contribute to a more sustainable agricultural future that benefits both regions.

Cooperation Partners:

Scotlands' Rural College

University of Edinburgh

Funding: MJFF, 465.000 EUR

Project Details:
Study Rationale: Parkinson’s disease (PD) is a complex neurodegenerative disorder marked by the loss of dopaminergic neurons, however the underlying exact reasons are still not fully understood. Current treatments focus on alleviating some of the symptoms of the disease, but do not stop disease progression. ACT-02, a new drug developed by Accure Therapeutics, offers a more comprehensive approach by addressing several key aspects of PD, such as alpha-synuclein aggregation, oxidative stress (cell respiration dysfunction) and inflammation. This multi-target strategy not only impacts on slowing disease progression but also improves motor and non-motor symptoms at the same time, offering new hope for managing PD more effectively.

Hypothesis: We hypothesize that inhibition of prolyl endopeptidase (PREP), an enzyme involved in protein aggregation and oxidative stress among other hallmarks of PD, will prevent neuronal death. ACT-02 treatment is expected to simultaneously improve motor and non-motor symptoms while slowing down disease progression, offering a comprehensive therapeutic approach for the treatment of PD.

Study Design: We aim to extend the tissue analysis and validate biomarkers in existing serum and brain tissue samples from transgenic animals (line 61; a reference model of PD), where we previously showed clear improvement of motor and non-motor symptoms, as well a decrease in α-synuclein aggregation and neuroinflammation, after short (1-month) ACT-02 treatment. These promising results support the design of a second efficacy study to assess the impact of longer/term ACT-02 treatment, to support phase II clinical trials. Simultaneously, we plan to complete the remaining experiments required for filing the Investigational New Drug (IND) to enable the Phase I clinical trial within the next 12 months.

Impact on Diagnosis/Treatment of Parkinson’s disease: The ACT-02 program offers a unique and distinct approach for PD treatment by targeting multiple pathways involved in the disease. ACT-02 treatment allows to slow disease progression and address both motor and non-motor symptoms, offering a broader strategy compared to therapies that focus on only one pathway.

Next Steps for Development: Having completed most of the regulatory and proof-of-concept pre-clinical studies required to reach first-in-human trials already, with support from the MJFF we aim to bring ACT-02 to the clinic within 12 months. Additional funding is needed to test the new formulation prototype and conduct longer efficacy study to support a Phase II clinical trial.

Cooperation Partners:

Accure Therapeutics

Funding: Biotech, 260.000 EUR

Project Details:
development of novel treatments

Project Details:
Preclinical investigations of the anticonvulsant efficacy range of azetukalner

Funding: Evangelisches Studienwerk Villigst, 44.500 EUR

Project Details:
Pre-clinical investigations of the anticonvulsant efficacy of a specific MAGL inhibitor

Project Details:
Few standardized studies are available on the effect of slow-release GnRH agonists in avian patients. With this background, the aim of this study is to examine the influence of deslorelin, a slow-release GnRH agonist, on the gonadal activity of female and male budgerigars in order to optimize the clinical use of this drug. The activity of the gonads will be examined, for example, by determining the sex hormones and by radiographic assessment of the reproductive organs.

Funding: MEKUN, 394.000 EUR

Project Details:
Amphibians worldwide are confronted with a variety of factors causing a rapid population declines. In Schleswig-Holstein, these population declines can also be in otherwise widely distributed species and cannot be explained by structural parameters alone, such as habitat loss and alteration. Other factors influencing amphibians can include toxicological contamination and invasive pathogens. The effects of those stressors on our native amphibians are largely unknown. Furthermore, the extent to which the different stressors interact is largely unknown, although it is assumed that they potentiate each other. In order to implement successful conservation measures in the long term, it is important to identify and evaluate the relevant stressors. Based on preliminary studies carried out at the Institute for Terrestrial and Aquatic Wildlife Research (ITAW) from 2021 to 2023, the project aims to investigate possible stressors for amphibians native to Schleswig-Holstein. This includes the continued monitoring of pathogens, such as fungi originating from Asia (Batrachochytrium dendrobatidis (Bd) and B. salamandrivorans (Bsal)) as well as Ranaviruses and herpes viruses. In addition, of animal-related data as well as data on habitat-specific factors are collected to be able to explain differences in the occurrence of infectious agents. The collection of habitat-related data includes water quality characteristics (e.g. pH value, water temperature) and analyses of possible contaminants correlation with utilization, structure and surrounding vegetation over the course of the year.
In addition to recording possible stressors and their interaction, this study aims to develop a basis to evaluate habitats in the course of species protection measures such as reintroduction projects.

Cooperation Partners:

Rachel Marschang und Christoph Leineweber, LABOKLIN GmbH, Bad Kissingen

Annika Jahnke und Nadin Ulrich, Helmholtz-Zentrum für Umweltforschung, Leipzig

Krishna Das, University oh Liege, Lüttich, Belgium

Arne Drews, Landesamt für Umwelt, Schleswig-Holstein

Christian Winkler, faunistische Gutachten

René Seifert, Bündnis Naturschutz in Dithmarschen e. V.

Funding: Ministerium für Energie­wende, Klimaschutz, Umwelt und Natur (MEKUN), 766.851 EUR

Project Details:
Common Eider (Somateria mollissima) is classified as endangered in Europe due to continuous the population declines. Meanwhile, its occurrence along the coast of Schleswig-Holstein has potential for conflict with the culturally established and economically important fisheries.
The methods investigated in the pilot study showed promising effects: the tested eider protection fence effectively protected the mussel lines from feeding damage by common eiders and there were clear differences to control lines that were freely accessible to the eiders. However, the measures have so far only been tested on a small scale. In order to investigate the practicability on a realistic scale, this follow-up project aims to extend the to a larger area and possibly include other deterring methods that have not been used in the pilot project.

The long-term objective is to find practicable methods that are applicable to commercially operated mussel farms and at the same time function in terms of animal welfare or can even contribute to the reduction of bycatch in other areas.

At the same time, necropsies of dead common eiders will be continued in order to provide information on the incidence of disease within the population, identify pathological changes and classify these in the context of the population decline. This includes bacteriological, virological and parasitological analyses. In addition, toxicological examinations will provide information on the animals' exposure to environmental pollutants.

Funding: Europäische Union, 142.547 EUR

Project Details:
The European Partnership on Animal Health and Welfare (EUPAHW) is a research and innovation initiative funded by the European Commission (EC) to control infectious diseases of animals, and to promote animal welfare. Due to the close link between animal health, animal welfare and human well-being, the One Health-One Welfare perspective takes a prominent position in the EUPAHW. Within the EUPAHW, the Institute for Terrestrial and Aquatic Wildlife Research will work with other partners on wildlife-livestock-human interface. The overall objective is to integrate the health of wild mammals and birds into the overall health surveillance and monitoring of livestock. Wildlife health surveillance contributes to the assessment of environmental health because wild animals may serve as sentinels for both terrestrial and aquatic ecosystems. Improving wildlife population monitoring and surveillance of wildlife pathogens/diseases aims to detect the emergence of pathogens and reduce the risk of transmission of infectious diseases between wildlife and livestock and even humans. The information is needed to design, apply and support sustainable livestock and wildlife management systems. In this context, the EUPAHW will assess the impact of climate change and human/anthropogenic activities such as hunting, trade, feeding, rewilding and translocation of wildlife on the spread of diseases and the establishment of invasive species.

Cooperation Partners:

56 Forschungsinstitutionen aus Europa (https://www.eupahw.eu)

Funding: DFG, 122.183 EUR

Project Details:
Enteroinvasive bacterial pathogens are serious health threats for humans and animals as they can overcome the physical and innate immune barrier by the intestinal epithelium. There is evidence that such pathogens exploit host transcytotic pathways of different intestinal epithelial cell types that are otherwise used for antigen and nutrient uptake. Intestinal transcytosis and transcytosis pathways may considerably contribute to the disease outcome of infection. However, these processes are not fully understood. For example, it is not clear whether different pathogens share pathways for translocation. This project describes a research collaboration to clarify transcytosis of the enteroinvasive intracellular bacterial pathogens Salmonella enterica and Mycobacterium avium. Both Salmonella serovars and M. avium subspecies are known to use different intestinal cell types for entry into the host. However, translocation through the cells is largely unknown. The aim of this project is to define the mechanisms of translocation and the promoting factors by infecting intestinal epithelial organoids.

Cooperation Partners:

Prof.Dr. Guntram Graßl

Institut für Medizinische Mikrobiologie und Krankenhaushygiene

Medizinische Hochschule Hannover